The drugs Viagra, Cialis and Levitra could be heading into some serious competition in the erectile dysfunction stakes if research that is being done on genetic ways of stopping impotence bears fruit. Research in the United States has shown that gene therapy may be the answer for many men who suffer from impotence and this will negate the need to take erectile dysfunction medication. The studies that are ongoing are only in the first Phase and so whether they will be successful or not is still unknown but if the results are positive it could mean that Pfizer’s Viagra will be meeting its match and Cialis and Levitra will be also. The Phase one tests are merely to establish if the drug is safe rather than whether it is effective and for this reason it will be many years before concrete results are produced.

Nevertheless the small study has shown that some of the men who were administered with one injection into their corpus cavernosum of hMaxi-K were seen to get better and harder erections. The injections that were given to the penis are designed to be a one-injection cure that doesn’t need to be repeated.

If this research proves all OK then it may be that many men will rather have one injection that would enable them to have sex whenever they wanted rather than have to take Viagra, Cialis or Levitra before they had sex.

Ukmedix will be reporting on the results of this interesting research and will let Ukmedix readers know the outcome of the research. Pfizer, Eli Lily and Bayer must be carefully monitoring the results too as the results will seriously affect their profits. Erectile dysfunction drugs are likely to still maintain some popularity even with a gene remedy available as they will be used more for people with mild erectile dysfunction who just need an extra boost every now and then.